ES2033850T5 - Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas. - Google Patents
Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas.Info
- Publication number
- ES2033850T5 ES2033850T5 ES87306174T ES87306174T ES2033850T5 ES 2033850 T5 ES2033850 T5 ES 2033850T5 ES 87306174 T ES87306174 T ES 87306174T ES 87306174 T ES87306174 T ES 87306174T ES 2033850 T5 ES2033850 T5 ES 2033850T5
- Authority
- ES
- Spain
- Prior art keywords
- days
- dosage form
- combination
- treatment
- intended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
SE DESCRIBE AQUI UN METODO PARA APLICAR UNA TERAPIA DE SUSTITUCION HORMONAL Y UN ANTICONCEPTIVO A UNA MUJER PREMENOPAUSICA, QUE COMPRENDE ADMINSTRAR A UNA MUJER PREMENOPAUSICA QUE LA NECESITA UNA FORMA DE DOSIFICACION COMBINADA DE UN ESTROGENO SELECCIONADO DE ENTRE 0,5-2,0 MG DE 17 BETA-ESTRADIOL, 0,008-0,030 MG DE ETINIL ESTRADIOL Y 0,015-0,060 MG DE MESTRANOL; Y UN PROGETOGENO SELECIONADO DE ENTRE 0,025-0,100 MG DE LEVONORGESTREL, 0,010-0, 070 MG DE GESTODENE, 0,025-0,100 MG DE DESOGESTREL 0,025-0,100 MG DE 3-CETODESOGESTREL Y 0,085-0,35 MG DE NORETINDRONA, ADMINISTRANDOSE DICHA FORMA DE DOSIFICACION COMBINADA DURANTE 23-25 DIAS Y EMPEZANDO EN EL PRIMER DIA DEL CICLO MENSTRUAL, SEGUIDA POR 2 A 5 DIAS SIN PILDORAS O CON PILDORAS PLACEBO DURANTE UN TOTAL DE 28 DIAS DEL CICLO DE ADMINSTRACION. LA FORMA DE DOSIFICACION PREFERIDA DE LA INVENCION ES UNA COMBINACION DE 1 MG DE 17BETA-ESTRADIOL Y 0,050 O 0,075 MG DE LEVONORGESTREL. EL CICLO DE ADMINISTRACION PREFERIDO DE LA INVENCION ES LA ADMINISTRACION DE LA FORMA DE DOSIFICACION COMBINADA DURANTE LOS PRIMEROS 24 DIAS DEL CICLO MENSTRUAL Y NINGUNA FORMA DE DOSIFICACION DURANTE LOS ULTIMOS 4 DIAS DEL CICLO MENSTRUAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88597186A | 1986-07-15 | 1986-07-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2033850T3 ES2033850T3 (es) | 1993-04-01 |
ES2033850T5 true ES2033850T5 (es) | 2001-07-01 |
Family
ID=25388101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87306174T Expired - Lifetime ES2033850T5 (es) | 1986-07-15 | 1987-07-13 | Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0253607B2 (es) |
JP (1) | JP2645510B2 (es) |
KR (1) | KR960001371B1 (es) |
AT (1) | ATE75401T1 (es) |
AU (1) | AU597084B2 (es) |
CY (1) | CY1725A (es) |
DE (1) | DE3778599D1 (es) |
DK (2) | DK174724B1 (es) |
ES (1) | ES2033850T5 (es) |
GB (1) | GB2192542B (es) |
GR (1) | GR3004472T3 (es) |
HK (1) | HK67393A (es) |
IE (1) | IE61236B1 (es) |
LU (1) | LU90634I2 (es) |
NL (1) | NL300025I2 (es) |
PH (1) | PH25944A (es) |
PT (1) | PT85305B (es) |
SG (1) | SG55093G (es) |
WO (1) | WO1988000469A1 (es) |
ZA (1) | ZA875010B (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
CH674618A5 (es) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
DE3864210D1 (de) * | 1987-07-06 | 1991-09-19 | Akzo Nv | Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden. |
ES2169030T3 (es) * | 1987-09-24 | 2002-07-01 | Jencap Res Ltd | Envases de anticonceptivos que contienen estrogeno y progestina. |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
DE3916112A1 (de) * | 1989-05-16 | 1990-11-22 | Schering Ag | Dihydrospirorenon als antiandrogen |
US5043331A (en) * | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
IE62665B1 (en) * | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
MX9301121A (es) * | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
US7704983B1 (en) | 1992-03-02 | 2010-04-27 | Eastern Virginia Medical School | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception |
DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
US5552394A (en) * | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
US5922349A (en) * | 1995-09-28 | 1999-07-13 | Schering Aktiengesellschaft | Hormone replacement therapy method and hormone dispenser |
US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
ATE271386T1 (de) * | 1996-07-26 | 2004-08-15 | Wyeth Corp | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
JP2001513566A (ja) * | 1997-08-27 | 2001-09-04 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物 |
US6787531B1 (en) | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
FR2832065B1 (fr) | 2001-11-13 | 2004-11-05 | Besins Int Belgique | Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations |
WO2003049744A1 (en) | 2001-12-05 | 2003-06-19 | Barr Laboratories, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
US7772219B2 (en) | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
CN101001631B (zh) | 2003-07-16 | 2014-08-06 | 特卫华妇女健康有限公司 | 利用连续给予雌激素的避孕方案的激素治疗方法 |
WO2005049142A2 (en) * | 2003-11-14 | 2005-06-02 | Warner Chilcott Company, Inc. | Graduated estrogen contraceptive |
EP1535618A1 (en) | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
DE102004026679A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
DE102004026670A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
DE102004026671A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US20060135496A1 (en) | 2004-10-07 | 2006-06-22 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
UY29527A1 (es) * | 2005-05-13 | 2006-12-29 | Schering Ag | Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato. |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
WO2007076144A2 (en) | 2005-12-27 | 2007-07-05 | Duramed Pharmaceuticals, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
TW200840595A (en) * | 2006-12-12 | 2008-10-16 | Organon Nv | Oral contraceptive spray |
ES2531929T3 (es) * | 2006-12-20 | 2015-03-20 | Teva Women's Health, Inc. | Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas |
WO2009082478A1 (en) | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
WO2009112232A2 (en) * | 2008-03-10 | 2009-09-17 | Vladimir Hanes | New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen |
EP2343963B1 (en) | 2008-10-08 | 2019-04-10 | Agile Therapeutics, Inc. | Transdermal delivery |
ES2795455T3 (es) | 2008-10-08 | 2020-11-23 | Agile Therapeutics Inc | Suministro transdérmico |
US9192614B2 (en) | 2008-10-08 | 2015-11-24 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
WO2010111488A1 (en) | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
US20180125860A1 (en) * | 2015-05-18 | 2018-05-10 | Agile Therapeutics, Inc. | Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects |
EP3272333A1 (en) | 2016-07-22 | 2018-01-24 | Chemo Research, S.L. | Vaginal composition comprising a combination of estrogen and vitamin d |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3669502A (en) † | 1971-01-05 | 1972-06-13 | Simpson Timber Co | Pneumatic spreader stoker |
US3836651A (en) * | 1972-02-22 | 1974-09-17 | Biolog Concepts Inc | Novel oral contraceptive combination |
DE2310963A1 (de) † | 1972-04-14 | 1974-09-05 | Schering Ag | Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten |
DE2365103C3 (de) † | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
NL8001593A (nl) * | 1980-03-18 | 1981-10-16 | Akzo Nv | Meerfasisch combinatiepreparaat voor orale anticonceptie. |
US4425339A (en) * | 1981-04-09 | 1984-01-10 | Syntex (U.S.A.) Inc. | Treatment of menopausal symptoms |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US4544554A (en) * | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
DE3347125A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
ZA87332B (en) † | 1986-02-27 | 1987-08-26 | Warner Lambert Co | Compositions containing fixed combinations |
-
1987
- 1987-07-08 IE IE183387A patent/IE61236B1/en active Protection Beyond IP Right Term
- 1987-07-08 DK DK198703518A patent/DK174724B1/da not_active IP Right Cessation
- 1987-07-09 ZA ZA875010A patent/ZA875010B/xx unknown
- 1987-07-09 AU AU75379/87A patent/AU597084B2/en not_active Expired
- 1987-07-10 WO PCT/US1987/001646 patent/WO1988000469A1/en unknown
- 1987-07-10 JP JP62504480A patent/JP2645510B2/ja not_active Expired - Lifetime
- 1987-07-10 PT PT85305A patent/PT85305B/pt unknown
- 1987-07-10 KR KR1019880700286A patent/KR960001371B1/ko not_active IP Right Cessation
- 1987-07-10 PH PH35524A patent/PH25944A/en unknown
- 1987-07-13 AT AT87306174T patent/ATE75401T1/de active
- 1987-07-13 ES ES87306174T patent/ES2033850T5/es not_active Expired - Lifetime
- 1987-07-13 EP EP87306174A patent/EP0253607B2/en not_active Expired - Lifetime
- 1987-07-13 DE DE8787306174T patent/DE3778599D1/de not_active Expired - Lifetime
- 1987-07-13 GB GB8716431A patent/GB2192542B/en not_active Expired - Lifetime
- 1987-07-14 DK DK365887A patent/DK365887D0/da not_active Application Discontinuation
-
1992
- 1992-04-30 GR GR920400741T patent/GR3004472T3/el unknown
-
1993
- 1993-04-29 SG SG55093A patent/SG55093G/en unknown
- 1993-07-15 HK HK673/93A patent/HK67393A/xx not_active IP Right Cessation
-
1994
- 1994-05-06 CY CY172594A patent/CY1725A/xx unknown
-
2000
- 2000-09-06 LU LU90634C patent/LU90634I2/fr unknown
- 2000-11-03 NL NL300025C patent/NL300025I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
KR880701553A (ko) | 1988-11-03 |
ZA875010B (en) | 1989-02-22 |
DK351887A (da) | 1988-01-16 |
GR3004472T3 (es) | 1993-03-31 |
JPH01500431A (ja) | 1989-02-16 |
EP0253607B2 (en) | 2001-05-23 |
WO1988000469A1 (en) | 1988-01-28 |
PT85305B (pt) | 1990-03-30 |
ATE75401T1 (de) | 1992-05-15 |
GB8716431D0 (en) | 1987-08-19 |
LU90634I2 (fr) | 2000-12-15 |
GB2192542A (en) | 1988-01-20 |
AU597084B2 (en) | 1990-05-24 |
AU7537987A (en) | 1988-01-21 |
PH25944A (en) | 1991-12-19 |
KR960001371B1 (ko) | 1996-01-26 |
PT85305A (en) | 1987-08-01 |
DK174724B1 (da) | 2003-10-06 |
NL300025I1 (nl) | 2001-01-02 |
CY1725A (en) | 1994-05-06 |
HK67393A (en) | 1993-07-23 |
IE871833L (en) | 1988-01-15 |
JP2645510B2 (ja) | 1997-08-25 |
DK351887D0 (da) | 1987-07-08 |
DE3778599D1 (de) | 1992-06-04 |
GB2192542B (en) | 1990-05-02 |
NL300025I2 (nl) | 2004-08-02 |
SG55093G (en) | 1993-07-09 |
IE61236B1 (en) | 1994-10-19 |
EP0253607A1 (en) | 1988-01-20 |
ES2033850T3 (es) | 1993-04-01 |
EP0253607B1 (en) | 1992-04-29 |
DK365887D0 (da) | 1987-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2033850T5 (es) | Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas. | |
EP0717626B1 (en) | Preparation for substitution therapy, containing at least one progestogen and at least one extrogen | |
PT911029E (pt) | Contraceptivos orais em doses ultra-baixas com menos hemorragias menstruais e com eficacia prolongada | |
US3639600A (en) | Process of establishing cyclicity in a human female | |
RU96115196A (ru) | Состав для контрацепции | |
JPH04290830A (ja) | 避妊薬処方物 | |
CA2179728A1 (en) | Composition for a contraceptive comprising an estrogen and a gestagen | |
JP2000502108A (ja) | ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット | |
NZ333750A (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
JP2942560B2 (ja) | エストロゲン欠乏症治療用組成物 | |
CA2311937A1 (en) | Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis | |
CA2171460C (en) | Preparation for substitution therapy, containing at least one progestogen and at least one extrogen | |
Vasilev | Triphasic hormonal contraceptives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 253607 Country of ref document: ES |
|
SPCF | Request for supplementary protection certificate filed |
Free format text: GESTODENO + ETINILESTRADIOL (MENESSE) Spc suppl protection certif: C200000027 Filing date: 20001110 |
|
SPCG | Supplementary protection certificate granted |
Free format text: GESTODENO + ETINILESTRADIOL (MENESSE) Spc suppl protection certif: C200000027 Filing date: 20001110 Expiry date: 20120713 Effective date: 20031008 |